*Professor, Doctor of Pharmaceutical Sciences, Department of “Pharmaceutical Organization and Pharmaceutical Technology”, Tashkent Pharmaceutical Institute, Uzbekistan
***PhD, Head of the Research Center “MED STANDART”, LLC, Uzbekistan
Online published on 12 October, 2021.
Preclinical studies of the preparation “Extract of rhizomes of turmeric long”were carried out in terms of acute toxicity and anti-inflammatory activity. According to the results of the study of acute toxicity, it was found that the preparation “Extract of rhizomes of turmeric long”, has high harmlessness, as to the fifth class of toxicity “Practically non-toxic”. The study of the anti-inflammatory activity of the drug proved the presence of reliable anti-inflammatory activity in the drug.
Turmeric Long, Extract, Rhizome, Acute Toxicity, Anti-Inflammatory Activity, Preclinical Studies
